mifepristone
State health department fires employee over abortion drug reference in newsletter
Two Ohio Department of Health employees lost their jobs after the publication of a newsletter with notice of a training program for a drug used in medical abortions. One was fired, another resigned. Jessica Warner, who worked in the sexually transmitted infections unit of the Bureau of Infectious Diseases, authored the department’s STI prevention training […]
Ohio House considers requiring docs to use controversial abortion ‘reversal’ messaging
A bill that would require Ohio doctors to provide information about a medically unsupported abortion “reversal” procedure or risk jail time is back under consideration by the Ohio legislature. House Bill 378 was introduced in the House Health Committee on Tuesday, for its first hearing since being brought to the General Assembly in July. The […]
Lifting federal regulations on medication abortion won’t guarantee access in restrictive states like Ohio
By Danielle Bessett, PhD., and Kelsey Mello Advocates around the country are applauding the U.S. Food and Drug Administration’s (FDA) decision earlier this month to review its longstanding restriction on the medication abortion drug mifepristone. Medication abortion is a safe and effective method to end a pregnancy, usually in the privacy of a patient’s own […]
Abortion bills back on the dockets as legislature committees restart business
As the Ohio legislature comes back, abortion restrictions are back on the table in committees. The House and Senate are both considering several bills on the topic, and a few of them have been moved on for committee consideration in the next few weeks. As the coronavirus spread caused the need for more uses for […]
Ohio Senator proposes ban on abortion drugs via telemedicine
An Ohio Senator is looking for co-sponsors to a bill that would ban telemedicine as a way of receiving abortion medication. State Sen. Steve Huffman, R-Tipp City, sent a letter to senate members on Tuesday explaining the bill that would affect the prescription of a two-pill regimen, Mifepristone and Misoprostol, used in inducing an abortion. […]